Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3207530 | 0.85 | IDO1 (0.31) | — | |
| SCHEMBL1396737 | 0.85 | CYP1A2 (0.31) | CDC25A | |
| SCHEMBL3198409 | 0.84 | — | — | |
| SCHEMBL1396771 | 0.82 | IDO1 (0.31) | — | |
| Propionic Acid SCHEMBL1044207 | 0.81 | — | — | |
| SCHEMBL5674761 | 0.80 | — | — | |
| SCHEMBL27237559 | 0.80 | CPB2 (0.30) | — | |
| SCHEMBL13209034 | 0.79 | IDO1 (0.32) | — | |
| SCHEMBL31141331 | 0.79 | IDO1 (0.32) | — | |
| SCHEMBL1396689 | 0.79 | IDO1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197243-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| EP-4347757-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| WO-2022234149-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | claimed |
| US-10947483-B2 | Encapsulates | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2021-03-16 | — | — | US | claimed |
| US-10604728-B2 | Encapsulates | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2020-03-31 | — | — | US | claimed |
| US-20200071639-A1 | Encapsulates | PROCTER & GAMBLE INT OPERATIONS SA (CH) | 2020-03-05 | — | — | US | claimed |
| US-10434485-B2 | Compositions comprising encapsulated actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2019-10-08 | — | — | US | claimed |
| EP-3262148-B1 | A SYNERGISTIC PERFUMING COMPOSITION | FIRMENICH & CIE (CH) | 2018-11-07 | — | — | EP | claimed |
| US-9878299-B2 | Methods for encapsulation of actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2018-01-30 | — | — | US | claimed |
| EP-3223801-A1 | METHODS FOR ENCAPSULATION OF ACTIVES WITHIN DROPLETS AND OTHER COMPARTMENTS | The Procter & Gamble Company (US) | 2017-10-04 | — | — | EP | claimed |
| US-9718044-B2 | Compositions comprising encapsulated actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-01 | — | — | US | claimed |
| US-20170130172-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-05-11 | — | — | US | claimed |
| US-20160304817-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2016-10-20 | — | — | US | claimed |
| WO-2016085742-A1 | METHODS FOR ENCAPSULATION OF ACTIVES WITHIN DROPLETS AND OTHER COMPARTMENTS | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-02 | — | — | WO | claimed |
| US-20160145535-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | claimed |
| US-20160130537-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2016-05-12 | — | — | US | claimed |
| EP-2806018-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2014-11-26 | — | — | EP | claimed |
| US-20140338134-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-20 | — | — | US | claimed |
| US-20140342972-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-20 | — | — | US | claimed |
| JP-6072952-A | — | — | None | — | — | JP | disclosed |
| US-20260027132-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2026-01-29 | — | — | US | disclosed |
| US-12453736-B2 | Fragrance compositions and use thereof for improving sleep | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2025-10-28 | — | — | US | disclosed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | disclosed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | disclosed |
| US-20240197243-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | disclosed |
| EP-4347757-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | disclosed |
| US-20240050917-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | FIRMENICH SA (CH) | 2024-02-15 | — | — | US | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| US-11820961-B2 | Musk compositions and methods of use thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-11-21 | — | — | US | disclosed |
| EP-3313361-B1 | MUSK COMPOSITION AND METHODS OF USE THEREOF | TAKASAGO PERFUMERY CO LTD (JP) | 2023-09-13 | — | — | EP | disclosed |
| WO-2022234149-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | disclosed |
| EP-4039244-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-08-10 | — | — | EP | disclosed |
| US-20220220412-A1 | MUSK COMPOSITIONS AND METHODS OF USE THEREOF | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2022-07-14 | — | — | US | disclosed |
| EP-3313362-B1 | MUSK COMPOSITIONS AND METHODS OF USE THEREOF | TAKASAGO PERFUMERY CO LTD (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-11236288-B2 | Fragrance materials | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-02-01 | — | — | US | disclosed |
| US-20210230504-A1 | FRAGRANCE MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-29 | — | — | US | disclosed |
| US-20210198229-A1 | FRAGRANCE AND FLAVOR MATERIALS FROM 1-(2-HYDROXY-4-METHYLCYCLOHEXYL)-ETHANONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-01 | — | — | US | disclosed |
| US-10947483-B2 | Encapsulates | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2021-03-16 | — | — | US | disclosed |
| US-20210008082-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-01-14 | — | — | US | disclosed |
| US-20200407301-A1 | FRAGRANCE AND FLAVOR MATERIALS DERIVED FROM 1-(4-METHYLCYCLOHEX-1-EN-1-YL)ETHAN-1-ONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2020-12-31 | — | — | US | disclosed |
| US-10604728-B2 | Encapsulates | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2020-03-31 | — | — | US | disclosed |
| US-20200078758-A1 | Methods and Systems for Forming Microcapsules | THE PROCTER & GAMBLE COMPANY | 2020-03-12 | — | — | US | disclosed |
| US-20200078757-A1 | Methods and Systems for Forming Microcapsules | THE PROCTER & GAMBLE COMPANY | 2020-03-12 | — | — | US | disclosed |
| US-20200078759-A1 | Methods and Systems for Forming Microcapsules | THE PROCTER & GAMBLE COMPANY | 2020-03-12 | — | — | US | disclosed |
| US-20190344237-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | PROCTER & GAMBLE (US) | 2019-11-14 | — | — | US | disclosed |
| US-10434485-B2 | Compositions comprising encapsulated actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2019-10-08 | — | — | US | disclosed |
| US-9878299-B2 | Methods for encapsulation of actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2018-01-30 | — | — | US | disclosed |
| US-20170296996-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | PROCTER & GAMBLE (US) | 2017-10-19 | — | — | US | disclosed |
| US-9718044-B2 | Compositions comprising encapsulated actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-01 | — | — | US | disclosed |
| US-20170130172-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-05-11 | — | — | US | disclosed |
| US-20160304817-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2016-10-20 | — | — | US | disclosed |
| US-20160144329-A1 | Systems for Encapsulation of Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | disclosed |
| US-20160144330-A1 | Methods for Encapsulation of Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | disclosed |
| US-20160145535-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | disclosed |
| US-20160130537-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2016-05-12 | — | — | US | disclosed |
| EP-2806018-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2014-11-26 | — | — | EP | disclosed |
| US-20140342972-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-20 | — | — | US | disclosed |
| US-20140338134-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-20 | — | — | US | disclosed |
| EP-2799864-A1 | Method to evaluate fragrance compositions | The Procter and Gamble Company (US) | 2014-11-05 | — | — | EP | disclosed |
| EP-2799863-A1 | Method to evaluate fragrance compositions | The Procter and Gamble Company (US) | 2014-11-05 | — | — | EP | disclosed |
| US-20140135402-A1 | CYCLODODECADIENONE DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2014-05-15 | — | — | US | disclosed |
| US-6734158-B2 | USING 6-METHYL-7-OXA-7-THIA-4AZASPIRO(4.4)NONANE | FIRMENICH SA (CH) | 2004-05-11 | — | — | US | disclosed |
| JP-H0672952-A | IMPROVEMENT, EMPHASIS, IMPARTION OR MODIFICATION OF FRAGRANCE CHARACTERISTIC OF NEW ESTER COMPOUND, PERFUMERY COMPOSITION AND ODORIZING ARTICLE AND PRODUCTION OF ODORIZING COMPOSITION AND ARTICLE AND NEW COMPOUND AND THEIR INTERMEDIATES | FIRMENICH SA | 1994-03-15 | — | — | JP | disclosed |
| JP-H0672952-A | IMPROVEMENT, EMPHASIS, IMPARTION OR MODIFICATION OF FRAGRANCE CHARACTERISTIC OF NEW ESTER COMPOUND, PERFUMERY COMPOSITION AND ODORIZING ARTICLE AND PRODUCTION OF ODORIZING COMPOSITION AND ARTICLE AND NEW COMPOUND AND THEIR INTERMEDIATES | FIRMENICH SA | 1994-03-15 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200071639-A1 | Encapsulates | LIPA, TTPA, CHMP4B | CDC25A 4031/4885LMNA 1015/4885BLM 1662/4885 |
| US-10947483-B2 | Encapsulates | LIPA, TTPA, CHMP4B | CDC25A 4031/4885LMNA 1015/4885BLM 1662/4885 |
| US-20210198229-A1 | FRAGRANCE AND FLAVOR MATERIALS FROM 1-(2-HYDROXY-4-METHYLCYCLOHEXYL)-ETHANONE | TAS2R5, TAS2R50, TAS2R20 | CDC25A 3145/4885LMNA 3583/4885BLM 4173/4885 |
| US-20240050917-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | CHMP4B, EXOSC9, F5 | CDC25A 1266/4885LMNA 2020/4885BLM 3637/4885 |
| US-20200407301-A1 | FRAGRANCE AND FLAVOR MATERIALS DERIVED FROM 1-(4-METHYLCYCLOHEX-1-EN-1-YL)ETHAN-1-ONE | TAS2R1, TAS1R1, TAS2R50 | CDC25A 2510/4885LMNA 2778/4885BLM 4511/4885 |
| US-20260027132-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | B2M, PER2, CHRM2 | CDC25A 1867/4885LMNA 761/4885BLM 3401/4885 |
| US-20220220412-A1 | MUSK COMPOSITIONS AND METHODS OF USE THEREOF | MUSK, MSI2, SYMPK | CDC25A 935/4885LMNA 1587/4885BLM 1701/4885 |
| US-11820961-B2 | Musk compositions and methods of use thereof | MUSK, MSI2, SYMPK | CDC25A 935/4885LMNA 1587/4885BLM 1701/4885 |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | CDC25A 2052/4885LMNA 3936/4885BLM 1809/4885 |
| US-20140135402-A1 | CYCLODODECADIENONE DERIVATIVES AS PERFUMING INGREDIENTS | CBR3, HPGD, CFD | CDC25A 1415/4885LMNA 2260/4885BLM 3452/4885 |
| US-11236288-B2 | Fragrance materials | NISCH, TRPA1, FAAH2 | CDC25A 3994/4885LMNA 3036/4885BLM 2707/4885 |
| US-20210230504-A1 | FRAGRANCE MATERIALS | NISCH, TRPA1, FAAH2 | CDC25A 3994/4885LMNA 3036/4885BLM 2707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.